Specifics of self-organization and properties of highly dilute aqueous solutions of polyoxidonium
- Autores: Ryzhkina I.1, Sergeeva S.1, Safiullin R.2, Ryzhkin S.3, Margulis A.4, Murtazina L.1, Timosheva A.1, Chernova A.1, Kadirov M.1, Konovalov A.1
-
Afiliações:
- A. E. Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Center of the Russian Academy of Sciences
- Kazan National Research Technological University
- Institute of Physics, Kazan Federal University
- Institute of Fundamental Medicine and Biology, Kazan Federal University
- Edição: Volume 65, Nº 6 (2016)
- Páginas: 1505-1513
- Seção: Full Articles
- URL: https://journals.rcsi.science/1066-5285/article/view/238390
- DOI: https://doi.org/10.1007/s11172-016-1477-x
- ID: 238390
Citar
Resumo
Using a combination of physicochemical methods (dynamic and electrophoretic light scattering (DLS and ELS, respectively), nanoparticle tracking analysis, atomic force and transmission electron microscopy (AFM and TEM, respectively), UV spectroscopy, conductometry, pH-metry, dielcometry), it was found that dilute solutions of a multicomponent drug immunomodulator polyoxidonium (PO) are nanoheterogeneous disperse systems, with their disperse phase undergoing considerable restructurings when diluting the solution in the range of calculated concentrations from 1∙10–1 to 1∙10–16 mg mL–1, which is reflected in the non-monotonous concentration dependencies of specific electroconductivity, dielectric permittivity, and pH of the solutions. Using ELS, AFM, TEM, and UV spectroscopy methods, it was found that the disperse phase with a size of hundreds of nanometers which forms at concentrations of ≤1∙10–5 mg mL–1, contains organized water structures substantiating the negative values of ζ-potential, which vary non-monotonously from–5 to–16 mV. Radioprotective properties of dilute solutions of PO (1∙10–1 and 1∙10–9 mg mL–1) were demonstrated for the first time when exposing the test mutant bacterial strain Salmonella typhimurium TA 100 (Ames test) to X-ray radiation in a dose of 7.50 mGy used for medical diagnostics.
Sobre autores
I. Ryzhkina
A. E. Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Center of the Russian Academy of Sciences
Autor responsável pela correspondência
Email: ryzhkina@iopc.ru
Rússia, 8 ul. Akad. Arbuzova, Kazan, 420088
S. Sergeeva
A. E. Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Center of the Russian Academy of Sciences
Email: ryzhkina@iopc.ru
Rússia, 8 ul. Akad. Arbuzova, Kazan, 420088
R. Safiullin
Kazan National Research Technological University
Email: ryzhkina@iopc.ru
Rússia, 68 ul. K. Marksa, Kazan, 420015
S. Ryzhkin
Institute of Physics, Kazan Federal University
Email: ryzhkina@iopc.ru
Rússia, 18 ul. Kremlevskaya, Kazan, 420008
A. Margulis
Institute of Fundamental Medicine and Biology, Kazan Federal University
Email: ryzhkina@iopc.ru
Rússia, 18 ul. Kremlevskaya, Kazan, 420008
L. Murtazina
A. E. Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Center of the Russian Academy of Sciences
Email: ryzhkina@iopc.ru
Rússia, 8 ul. Akad. Arbuzova, Kazan, 420088
A. Timosheva
A. E. Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Center of the Russian Academy of Sciences
Email: ryzhkina@iopc.ru
Rússia, 8 ul. Akad. Arbuzova, Kazan, 420088
A. Chernova
A. E. Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Center of the Russian Academy of Sciences
Email: ryzhkina@iopc.ru
Rússia, 8 ul. Akad. Arbuzova, Kazan, 420088
M. Kadirov
A. E. Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Center of the Russian Academy of Sciences
Email: ryzhkina@iopc.ru
Rússia, 8 ul. Akad. Arbuzova, Kazan, 420088
A. Konovalov
A. E. Arbuzov Institute of Organic and Physical Chemistry, Kazan Scientific Center of the Russian Academy of Sciences
Email: ryzhkina@iopc.ru
Rússia, 8 ul. Akad. Arbuzova, Kazan, 420088